Phase I Cancer Trials: A Collusion of Misunderstanding
The DOI matches its Crossref record.
Abstract
Physician-investigators face the daunting task of enrolling desperate patients into Phase I cancer trials that are not meant to be therapeutic. Patients doggedly regard the truals as therapeutic, and researchers tend to collaborate in their confusion by glossing the trials' true purposes and noting the occasional benefit that subjects accidentally receive. The disparity between hope and fact must be redressed by degrees, from many angles at once.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Clinical Trials and Medical Care: Defining the Therapeutic Misconception
Henderson, G. E., Churchill, L. R., Davis, A. M., Easter, M. M., Grady, C., Joffe, S., Kass, N., King, N. M. P., Lidz, C. W., Miller, F. G., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040324 · Cited by 466
Risks and Benefits of Phase 1 Oncology Trials, 1991 through 2002
Horstmann, E., McCabe, M. S., Grochow, L., Yamamoto, S., Rubinstein, L., Budd, T., Shoemaker, D., Emanuel, E. J., & Grady, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa042220 · Cited by 441
Therapeutic misconception and the appreciation of risks in clinical trials
Lidz, C. W., Appelbaum, P. S., Grisso, T., & Renaud, M. (2004) · Social Science & Medicine · doi:10.1016/s0277-9536(03)00338-1 · Cited by 330
Trends in the Risks and Benefits to Patients With Cancer Participating in Phase 1 Clinical Trials
Roberts, T. G. (2004) · JAMA · doi:10.1001/jama.292.17.2130 · Cited by 319
Chemotherapy Use among Medicare Beneficiaries at the End of Life
Emanuel, E. J., Young-Xu, Y., Levinsky, N. G., Gazelle, G., Saynina, O., & Ash, A. S. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-8-200304150-00011 · Cited by 317
Ethics of Phase 1 Oncology Studies: Reexamining the Arguments and Data
Agrawal, M., & Emanuel, E. J. (2003) · JAMA · doi:10.1001/jama.290.8.1075 · Cited by 190
“Critics argue that despite limited data, it seems that with such adverse effects and time commitments, quality of life must be compromised.(5,6,18,19) With a relatively low clinical benefit, a small but definite risk of death, serious but unquantified adverse effects, and substantial time commitment from patients, pha…”
BackgroundCommunication and Miscommunication in Informed Consent to Research
SANKAR, P. (2004) · Medical Anthropology Quarterly · doi:10.1525/maq.2004.18.4.429 · Cited by 99
Henderson, G. E. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31822a6c47 · Cited by 61
The clinical investigator-subject relationship: a contextual approach
Resnik, D. B. (2009) · Philosophy, Ethics, and Humanities in Medicine · doi:10.1186/1747-5341-4-16 · Cited by 32
Ethical flaws in the TeGenero trial
Shamoo, A., & Woeckner, E. (2007) · The American Journal of Bioethics · doi:10.1080/15265160601112204 · Cited by 20
Metadata
- Authors
- Miller, M.
- Venue
- The Hastings Center Report
- Publisher
- JSTOR
- Published
- 2000-07
- Volume
- 30
- Issue
- 4
- Pages
- 34
- ISSN
- 0093-0334 (ISSN-L)
- OpenAlex
- W2005634164
- Cited by
- 145
- References
- 0
- FWCI
- 7.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.